tiprankstipranks
Trending News
More News >
Carisma Therapeutics (CARM)
NASDAQ:CARM
US Market

Carisma Therapeutics (CARM) Income Statement

Compare
1,578 Followers

Carisma Therapeutics Income Statement

Last quarter (Q1 2025), Carisma Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Carisma Therapeutics's net income was $-9.27M. See Carisma Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 19.63M$ 14.92M$ 9.83M$ 26.54M$ 11.24M
Gross Profit
$ 19.63M$ -59.21M$ 3.74M$ 26.46M$ 11.24M
Operating Expenses
$ 81.81M$ 103.65M$ 59.91M$ 40.79M$ 28.38M
Depreciation and Amortization
$ 3.35M$ 2.84M$ 6.09M$ 85.00K$ 122.00K
EBITDA
$ -57.12M$ -85.89M$ -51.99M$ -40.11M$ -27.93M
Operating Income
$ -62.18M$ -88.73M$ -56.16M$ -40.79M$ -28.38M
Other Income/Expenses
$ 1.70M$ 1.85M$ -5.06M$ 10.00K$ 29.00K
Pretax Income
$ -60.48M$ -86.88M$ -61.23M$ -40.78M$ -28.35M
Net Income
$ -60.48M$ -86.88M$ -61.23M$ -40.77M$ -28.32M
Per Share Metrics
Basic EPS
$ -1.46$ -2.59$ -575.42$ -4.47$ -4.79
Diluted EPS
$ -1.46$ -2.59$ -575.42$ -4.47$ -4.79
Weighted Average Shares Outstanding
41.46M 33.52M 106.40K 9.12M 5.91M
Weighted Average Shares Outstanding (Diluted)
41.46M 33.52M 106.40K 9.12M 5.91M
Currency in USD

Carisma Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis